PLRZ
PolyrizonยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PLRZ
Polyrizon Ltd.
A biotech company, focused on the development and commercialization of innovative intranasal products
5 Ha-Tidhar Street, Raanana, 4366507, Israel
--
Polyrizon Ltd., was incorporated in Israel in January 2005. The company is a development-stage biotechnology company specializing in the development of Innovative Medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based protective barrier within the nasal cavity that prevents viruses and allergens from contacting nasal epithelial tissue. The company's C & C hydrogel technology consists of a mixture of naturally occurring building blocks, is provided in the form of a nasal spray, and can be used as a "biological mask" with a thin protective barrier inside the nasal cavity. The company is further developing certain aspects of its proprietary C & C hydrogel technology, such as bioadhesion and extended retention time at nasal deposition sites for intranasal administration. The company refers to its standalone platform technology that focuses on API nasal delivery as T & T.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
